medacta
-
Recon
Geisinger, Medacta announce first shoulder replacement with lifetime guarantee
Program builds on the success of the health system’s ProvenCare® surgeries on hips, knees and spines November 19, 2024 –…
Read More » -
Recon
Sterling Ridge Orthopaedic & Sports Medicine Sets Milestone with Dr. Paul Chin’s Innovative Shoulder Replacement Surgery
Dr. Paul Chin, MD, PhD, FAAOS, FAANA THE WOODLANDS, Texas, May 2, 2024 /PRNewswire/ — Sterling Ridge Orthopaedics & Sports Medicine proudly announces…
Read More » -
Recon
Medacta Announces the Launch of GMK SpheriKA, the World’s First Knee Implant Optimized for Kinematic Alignment (KA)
Castel San Pietro, October 30, 2023 – Medacta Group S.A. (‘Medacta,’ SIX: MOVE), a Swiss company featuring innovative, personalized, and…
Read More » -
Recon
Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular realignment
CASTEL SAN PIETRO, 5 July 2023- Medacta Group S.A. (‘Medacta,’ SIX: MOVE), a Swiss company featuring innovative, personalized, and sustainable solutions…
Read More » -
Spine
New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
CASTEL SAN PIETRO, 20 March 2023 – Medacta Group SA (“Medacta”, SIX:MOVE), a Swiss company specializing in the design, production,…
Read More » -
Recon
First NextAR surgeries in Japan with the award-winning NextAR Augmented Reality Surgical Platform
CASTEL SAN PIETRO, 11 January 2023 – Medacta is pleased to announce the first NextARTM surgeries have been successfully performed in Japan with its…
Read More » -
Recon
Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ Double Mobility Converter
CASTEL SAN PIETRO, 7 November 2022 – Medacta is pleased to announce that the first surgeries with the cobalt-free SensiTiN Double Mobility Converter have been successfully completed…
Read More » -
Spine
Medacta NextAR Spine wins the 2022 Spine Technology Award from Orthopedics This Week during North American Spine Society Annual Meeting
CASTEL SAN PIETRO, 14 October 2022 /OrthoSpineNews/- Medacta announced today its NextAR™ Spine application was awarded the 2022 Spine Technology…
Read More » -
Recon
Geisinger, Medacta partner to be first in the world to guarantee patient outcomes for knee, hip and shoulder replacement surgeries
CASTEL SAN PIETRO, Switzerland and DANVILLE, Pa. August 23, 2021 – Going for a joint replacement surgery is a major decision…
Read More » -
Recon
Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform
Game-changing innovation allowed surgeons to precisely replicate preoperative planning, while maintaining closer focus on their patients for improved accuracy and…
Read More » -
Regulatory
MicroPort Orthopedics and Medacta Agree to Settlement on Patent Claims
ARLINGTON, Tenn., July 14, 2021 /PRNewswire/ — MicroPort Orthopedics, a subsidiary of MicroPort Scientific Corporation (Stock doe: 00853.HK), and Medacta USA, Inc., a subsidiary…
Read More » -
Spine
Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery
Media release CASTEL SAN PIETRO, 28 April 2021 – Medacta announced today the first surgery utilizing its M.U.S.T.(R) LT, following clearance by the…
Read More » -
Financial
Medacta Group SA continues to outperform the market with a strong revenue acceleration in the second semester 2020
Press Release – 2020 Preliminary unaudited top-line figures • FY 2020 revenues were €302.5 million, only -2.1% on a constant…
Read More » -
Extremities
Medacta USA and OREF Launch 2020 Medacta Challenge Giving Campaign
Elizabeth Hofheinz, M.P.H., M.Ed. Medacta USA, an orthopedic manufacturer with an uncommon dedication to surgeon education, has teamed up with…
Read More » -
Recon
Medacta to Introduce NextAR(TM): First FDA-Cleared Augmented Reality-Based Surgical Platform for Total Knee Replacement
CASTEL SAN PIETRO, 13 July 2020 – Medacta today announced it has received clearance from the U.S. Food and Drug Administration…
Read More »